Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Diagnostic to detect DR-70 tumor marker: The first part of clinical trials with 200 patients and 200 healthy volunteers is completed and the data will be presen

AMDL Inc. (AMDD), Tustin, Calif.
Product: Diagnostic

Read the full 71 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE